|
| |
DomainDomain devotes considerable attention and resources to the earliest stage companies that we incorporate ourselves and initially support within our offices. In these instances, Domain forms a company to in-license the technology and, using our vast network of consultants, begins key development activities immediately.
Domain concurrently recruits a first class management team to assume day-to-day operations of the newly formed company. By combining appropriate technology, people and capital with the start-up infrastructure and network of contacts already available to Domain, we believe that our in-house-generated companies have an unusually strong competitive advantage from outset
| Contact Details: |
| 12481 High Bluff DriveSuite 150 |
| San Diego |
| California |
| 92130 |
| United States of America |
| Tel: | 858-480-2400 |
| Fax: | 858-480-2401 |
| Email: | |
| WWW: | www.domainvc.com/
|
|
Loading...
|
Recent Publications by Domain: |  |
Antibiotic Resistant Bacterial Profiles of Anaerobic Swine Lagoon Effluent.
Although land application of swine (Sus scrofa) manure lagoon effluent is... | 31st October, 2009
| USDA-ARS, Genetics and Precision Agriculture Unit, 801 HWY 12 E.,
| J Environ Qual. 2009 Oct 29;38(6):2431-2437. Print 2009.
DOI Direct Link |
Characterization of Selected Nutrients and Bacteria from Anaerobic Swine Manure Lagoons on Sow, Nursery, and Finisher Farms in the Mid-South USA.
Swine (Sus scrofa domestica) production in the Mid-South USA comprises... | 31st October, 2009
| USDA-ARS, Genetics and Precision Agriculture Research Unit, P.O. Box 5367,
| J Environ Qual. 2009 Oct 29;38(6):2422-2430. Print 2009.
DOI Direct Link |
A naturally shaped silicone ventricle evaluated in a mock circulation loop: a preliminary study.
Mock circulation loops are used to evaluate the performance of cardiac... | 20th August, 2009
| School of Engineering Systems and Medical Device Domain, Institute of
| J Med Eng Technol. 2009;33(3):185-91.
DOI Direct Link |
Work-rate of substitutes in elite soccer: A preliminary study.
The aim of this study was to investigate the work-rate of substitutes in... | 30th June, 2009
| Ecole des Metiers du Sport Professionnel, LOSC Lille Metropole Football
| J Sci Med Sport. 2009 Jun 26.
DOI Direct Link |
Proteomic profiling of distinct clonal populations of bone marrow mesenchymal stem cells.
Mesenchymal stem cells (MSCs) have attracted immense research interest in... | 26th June, 2009
| Medical Device Domain, Institute of Health and Biomedical Innovation,
| J Cell Biochem. 2009 Apr 1;106(5):776-86.
DOI Direct Link |
→View more Domain research publications. |
Press Releases on Domain:
|
 |
| Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction/Positive BPH Results |
18th November, 2009 |
Dong-A PharmTech Co. Ltd. |
SEOUL, South Korea, Nov. 18 /PRNewswire/ -- Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of
|
| Microchip Biotechnologies Raises $18.1M in Series B Financing |
12th November, 2009 |
Microchip Biotechnologies, Inc. |
PLEASANTON, Calif., Nov. 12 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI), a provider of integrated life science systems for microsample preparation and analysis, today announced an $18.1M
|
| Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference |
12th November, 2009 |
|
PRINCETON, New Jersey and SAN DIEGO, November 12 /PRNewswire/ -- Tobira Therapeutics, a clinical stage biotechnology company committed to
research and product discovery for the treatment of life
|
| Ocera Therapeutics Presents Clinical Data Demonstrating AST-120 Relieves Pruritus in Patients with Liver Cirrhosis at the 60th Annual AASLD Meeting |
2nd November, 2009 |
Ocera Therapeutics, Inc. |
BOSTON, Nov. 2 /PRNewswire/ -- Ocera Therapeutics, Inc. announced today that AST-120 (spherical carbon adsorbent) was shown to reduce the severity of pruritus (itching) in patients with chronic liver
|
| UCL (University College London) Liver Failure Group Present Two Studies on a Novel Treatment Option (OCR-002) for Complications of Hyperammonemia in Liver Failure at the 60th Annual AASLD Meeting |
2nd November, 2009 |
Ocera Therapeutics, Inc. |
BOSTON, Nov. 2 /PRNewswire/ -- UCL Liver Failure Group presented data from two studies with OCR-002 (L-ornithine phenylacetate) that suggest the potential for this novel therapeutic agent to impact
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 35 individuals from Domain using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 264 times since April 2007, the link to the organisation's website has been followed 33 times Search for more companies in San Diego Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Domain |
